Bone Biologics
Burlington
About Bone Biologics
Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $43.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: otcpink:BBLG
- Website: bonebiologics.com
- Phone: 781-552-4452
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/bone-biologics-82669 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.